FDA *xpands F*ll *pproval Of M*derna C*VID-19 Jab To Ch*ldren As Y*ung As 6 M*nths

The Food and Drug Administration (FDA) granted full approval of Moderna’s COVID-19 jab, Spikevax, in children 6 months through 11 years of age considered “increased risk” for COVID-19.

“Today we announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for Spikevax®, our COVID-19 vaccine,